BFA
NXTM

BlackRock Fund Advisors’s NxStage Medical Inc. NXTM Stock Holding History

BlackRock Fund Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$54.6M Buy
2,081,973
+202,835
+11% +$5.02M 0.01% 1621
2016
Q3 		$47M Buy
1,879,138
+57,187
+3% +$1.33M 0.01% 1619
2016
Q2 		$39.5M Buy
1,821,951
+116,680
+7% +$2.08M 0.01% 1643
2016
Q1 		$25.6M Sell
1,705,271
-17,956
-1% -$301K 0.01% 1843
2015
Q4 		$37.8M Buy
1,723,227
+70,696
+4% +$1.32M 0.01% 1666
2015
Q3 		$26.1M Sell
1,652,531
-77,031
-4% -$1.23M 0.01% 1828
2015
Q2 		$24.7M Sell
1,729,562
-24,579
-1% -$416K 0.01% 1984
2015
Q1 		$30.3M Buy
1,754,141
+25,234
+1% +$446K 0.01% 1836
2014
Q4 		$31M Buy
1,728,907
+237,397
+16% +$3.82M 0.01% 1797
2014
Q3 		$19.6M Sell
1,491,510
-51,445
-3% -$693K 0.01% 1971
2014
Q2 		$22.2M Sell
1,542,955
-86,319
-5% -$1.13M 0.01% 1959
2014
Q1 		$20.8M Buy
1,629,274
+61,012
+4% +$796K 0.01% 1978
2013
Q4 		$15.7M Sell
1,568,262
-283,439
-15% -$3.22M ﹤0.01% 2120
2013
Q3 		$24.4M Buy
1,851,701
+241,513
+15% +$3.17M 0.01% 1831
2013
Q2 		$23M Buy
+1,610,188
New +$20.2M 0.01% 1758

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

BlackRock Fund Advisors's NXTM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its NxStage Medical Inc. (NXTM) stake by 11% in Q4 2016, buying an estimated $5.02M and bringing the position to 2,081,973 shares worth $54.6M. The position accounts for 0.01% of the portfolio, ranked #1621.

BlackRock Fund Advisors first reported a position in NXTM in Q2 2013 and has held it in 15 quarters since. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • BlackRock Fund Advisors held 2,081,973 shares of NxStage Medical Inc. worth $54.6M as of Q4 2016.
  • BlackRock Fund Advisors bought 202,835 NxStage Medical Inc. shares in Q4 2016, an estimated $5.02M.
  • NxStage Medical Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1621 holding.
  • BlackRock Fund Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 15 quarters since.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.